Indefinite Delivery Contract 75N92023D00018
Award Date
9/14/23
Last Date to Order
9/13/33
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
State Of California Controllers Office
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
B599 - Special Studies/Analysis- Other
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Cedars-Sinai Medical Center to establish the Centralized Omics Resource for its Trans-Omics for Precision Medicine initiative. With a potential value of $500 million, this IDV enables task orders to be placed through September 2033 for complex data analysis, integration and management of large-scale genomic and health datasets to support the initiative's goals. The originating pre-solicitation...
The National Heart, Lung and Blood Institute, part of the National Institutes of Health and Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to New York Genome Center, Inc. doing business as Nygc. The potential value of the contract is $500 million to be ordered through September 2033. A firm fixed price delivery order for $742,360 was also awarded for RNA-Seq services to support the Trans-Omics for Precision Medicine initiative's Centralized Omics...
The federal contract IDV award is a $37.5 million Indefinite Delivery Contract (IDC) granted by the National Heart, Lung, and Blood Institute (NHLBI) to The Leland Stanford Junior University (Stanford University), a private research institution. The IDC, which runs through September 2033, tasks Stanford with providing data analysis, integration, and management services to support the NHLBI's Trans-Omics for Precision Medicine initiative. This includes work related to genomics, epigenomics,...
The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Psomagen Inc., a subsidiary of Macrogen, Inc., with a potential value of $500 million. The contract supports the Trans-Omics for Precision Medicine initiative through September 2033 by providing complex data analysis, integration, and management of large-scale genomic and health datasets. Specifically, the contractor will establish and operate the Centralized Omics Resource to perform...
The National Heart, Lung and Blood Institute (NHLBI) has awarded a $500,000,000 Indefinite Delivery Contract (IDC) to Stanford University to establish the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative. This single-award IDC, which runs through September 2033, tasks Stanford with providing data analysis, integration, and management services for omics and health data to support NIH's precision medicine efforts. The original pre-solicitation notice sought...
The federal contract IDV award is for the "Subpopulations and Intermediate Outcomes in COPD (SPIROMICS) III" project, which was awarded to The Regents of the University of California, San Francisco (UCSF) by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). This single-award Indefinite Delivery Contract has a ceiling value of $49,722,874 and a period of performance from June 18, 2024 to June 17, 2031. The contract aims to...
The federal contract IDV award is for the provision of Genomics Core Services to the U.S. Department of Veterans Affairs (VA). The prime contractor is The Regents of the University of California, San Francisco (UCSF), a leading academic medical center and research institution. The contract has a ceiling value of $233,964.24 and a period of performance through August 31, 2026. It is a single-award Indefinite Delivery Contract, with no set-asides used. The funding agency is the VA's Veterans...
This single-award IDV was issued by the Department of Health and Human Services National Institutes of Health Clinical Center to provide mutation analysis services. The potential value of the contract is $250,000. The prime contractor is Genedx, LLC of Gaithersburg, Maryland. The original solicitation sought continuation of existing mutation analysis testing services for the NIH Department of Laboratory Medicine. Due to the impacts of COVID-19, the final assessment of a previous contract was not...
The federal contract IDV award, 75N92019D00019, is a single-award Indefinite Delivery Contract (IDC) held by Information Management Services, Inc. (IMS), a for-profit Subchapter S corporation. The National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, awarded this $19.9 million IDC to IMS on November 16, 2018, with a period of performance through November 15, 2026. Under this IDC, IMS provides...
This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to provide Biomedical Information Management and Analytic Support Services. The multiple award IDV has a potential value of $148 million over five years. Task orders issued to date include $1.56 million for data analytics, statistical analysis and bioinformatics support for genome-wide association studies under cost plus fixed fee pricing to...